CN108837173A - A kind of eccentric sexual oppression dressing and its production method being closed after treatment for vein - Google Patents
A kind of eccentric sexual oppression dressing and its production method being closed after treatment for vein Download PDFInfo
- Publication number
- CN108837173A CN108837173A CN201810714443.5A CN201810714443A CN108837173A CN 108837173 A CN108837173 A CN 108837173A CN 201810714443 A CN201810714443 A CN 201810714443A CN 108837173 A CN108837173 A CN 108837173A
- Authority
- CN
- China
- Prior art keywords
- parts
- portions
- dressing
- hemostatic
- vein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003462 vein Anatomy 0.000 title claims abstract description 57
- 206010040007 Sense of oppression Diseases 0.000 title claims abstract description 45
- 230000001568 sexual effect Effects 0.000 title claims abstract description 45
- 238000004519 manufacturing process Methods 0.000 title claims description 16
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 96
- 239000004744 fabric Substances 0.000 claims abstract description 77
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 66
- 230000001954 sterilising effect Effects 0.000 claims abstract description 45
- 229940030225 antihemorrhagics Drugs 0.000 claims abstract description 43
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 38
- 239000002874 hemostatic agent Substances 0.000 claims abstract description 37
- 239000003814 drug Substances 0.000 claims abstract description 34
- 240000001592 Amaranthus caudatus Species 0.000 claims abstract description 33
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims abstract description 33
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 33
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 33
- 235000012735 amaranth Nutrition 0.000 claims abstract description 33
- 229910052742 iron Inorganic materials 0.000 claims abstract description 33
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 32
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 32
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 31
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 31
- 239000004178 amaranth Substances 0.000 claims abstract description 31
- 239000000463 material Substances 0.000 claims abstract description 26
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 23
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 23
- 241000218093 Phedimus aizoon Species 0.000 claims abstract description 21
- 240000004980 Rheum officinale Species 0.000 claims abstract description 21
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 21
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 21
- 241000219784 Sophora Species 0.000 claims abstract description 19
- 241001530209 Swertia Species 0.000 claims abstract description 17
- 244000307697 Agrimonia eupatoria Species 0.000 claims abstract description 15
- 235000000125 common agrimony Nutrition 0.000 claims abstract description 15
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims description 54
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 53
- 229940088594 vitamin Drugs 0.000 claims description 46
- 229930003231 vitamin Natural products 0.000 claims description 46
- 235000013343 vitamin Nutrition 0.000 claims description 46
- 239000011782 vitamin Substances 0.000 claims description 46
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 46
- 239000003795 chemical substances by application Substances 0.000 claims description 44
- 239000008280 blood Substances 0.000 claims description 42
- 210000004369 blood Anatomy 0.000 claims description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- 231100000241 scar Toxicity 0.000 claims description 39
- 238000000227 grinding Methods 0.000 claims description 38
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 31
- 239000003921 oil Substances 0.000 claims description 31
- 239000012790 adhesive layer Substances 0.000 claims description 30
- 230000000202 analgesic effect Effects 0.000 claims description 30
- 244000003416 Asparagus officinalis Species 0.000 claims description 29
- 238000001914 filtration Methods 0.000 claims description 28
- 235000015424 sodium Nutrition 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 23
- 239000012982 microporous membrane Substances 0.000 claims description 23
- 235000012907 honey Nutrition 0.000 claims description 22
- 241000717739 Boswellia sacra Species 0.000 claims description 21
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 21
- 229940009662 edetate Drugs 0.000 claims description 21
- 238000004659 sterilization and disinfection Methods 0.000 claims description 21
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 20
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 20
- 240000000260 Typha latifolia Species 0.000 claims description 20
- 235000008434 ginseng Nutrition 0.000 claims description 20
- 238000007598 dipping method Methods 0.000 claims description 19
- 239000012530 fluid Substances 0.000 claims description 19
- 241000219357 Cactaceae Species 0.000 claims description 16
- FEZWOUWWJOYMLT-DSRCUDDDSA-M cobalt;[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,1 Chemical compound [Co].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FEZWOUWWJOYMLT-DSRCUDDDSA-M 0.000 claims description 16
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 14
- 238000000498 ball milling Methods 0.000 claims description 13
- 238000009835 boiling Methods 0.000 claims description 13
- 241001313857 Bletilla striata Species 0.000 claims description 12
- 235000009108 Urtica dioica Nutrition 0.000 claims description 12
- 150000001637 borneol derivatives Chemical class 0.000 claims description 12
- 241000792500 Calvatia fenzlii Species 0.000 claims description 11
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 11
- 239000013013 elastic material Substances 0.000 claims description 11
- 238000005286 illumination Methods 0.000 claims description 10
- 239000011812 mixed powder Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 240000001949 Taraxacum officinale Species 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 238000010792 warming Methods 0.000 claims description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 8
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 229940116229 borneol Drugs 0.000 claims description 8
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 8
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 8
- 230000036407 pain Effects 0.000 claims description 7
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 7
- 235000019158 vitamin B6 Nutrition 0.000 claims description 7
- 239000011726 vitamin B6 Substances 0.000 claims description 7
- 229940011671 vitamin b6 Drugs 0.000 claims description 7
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 239000004863 Frankincense Substances 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 230000000249 desinfective effect Effects 0.000 claims description 2
- 240000004371 Panax ginseng Species 0.000 claims 1
- 244000274883 Urtica dioica Species 0.000 claims 1
- 230000000740 bleeding effect Effects 0.000 abstract description 14
- 230000000025 haemostatic effect Effects 0.000 abstract description 10
- 239000000843 powder Substances 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 5
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 240000001398 Typha domingensis Species 0.000 abstract 1
- 241000208340 Araliaceae Species 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 14
- 241000219422 Urtica Species 0.000 description 11
- 206010052428 Wound Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 230000035876 healing Effects 0.000 description 10
- 230000023597 hemostasis Effects 0.000 description 9
- 241000555712 Forsythia Species 0.000 description 8
- 241001415959 Grus japonensis Species 0.000 description 6
- 230000036592 analgesia Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 230000023555 blood coagulation Effects 0.000 description 4
- 210000001772 blood platelet Anatomy 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 210000003746 feather Anatomy 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 241000234427 Asparagus Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 240000007711 Peperomia pellucida Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- 244000046101 Sophora japonica Species 0.000 description 2
- 235000010586 Sophora japonica Nutrition 0.000 description 2
- 241000245665 Taraxacum Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000701 coagulant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- TYFJTEPDESMEHE-HNNXBMFYSA-N (3s)-6,8-dihydroxy-3-[2-(4-methoxyphenyl)ethyl]-3,4-dihydroisochromen-1-one Chemical compound C1=CC(OC)=CC=C1CC[C@@H]1OC(=O)C2=C(O)C=C(O)C=C2C1 TYFJTEPDESMEHE-HNNXBMFYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- TYFJTEPDESMEHE-UHFFFAOYSA-N agrimonolide Natural products C1=CC(OC)=CC=C1CCC1OC(=O)C2=C(O)C=C(O)C=C2C1 TYFJTEPDESMEHE-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001194 anti-hemostatic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940001501 fibrinolysin Drugs 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Animal Husbandry (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses the eccentric sexual oppression dressing after a kind of closure treatment for vein, are related to hemostatic material technical field, its key points of the technical solution are that including hemostatic gauze, hemostatic gauze includes fabric, the hemostatic agent being immersed in fabric and sterilizing medicament；The hemostatic agent is prepared by weight by following component：Tail 5-8 parts of Huanglong, 8-10 parts of iron amaranth grass, rich and honour 4-7 parts of dish, 5-9 parts of Seabuckthorn Oil, 3-6 parts of edetate sodium, 2-4 parts of Radix Notoginseng, 1-3 parts of aizoon stonecrop, 2.5-3.5 parts of saltcake, 1.5-2.5 parts of rheum officinale, 1-3 parts of sophora flower, 3-4 parts of hairyvein agrimony, 3-4 parts of folium artemisiae argyi, 1-3 parts of cattail pollen；The sterilizing medicament is prepared by weight by following component：9-11 parts of cassia bark, 5-9 parts of Swertia vacillana (Hance) Maxim., tail join 3-8 parts, 2-5 parts of the root of Dahurain angelica.The present invention solves the problems, such as that bleeding stopping period is long and wound is liable to infection, has achieved the effect that quick-acting haemostatic powder and sterilizing.
Description
Technical field
The present invention relates to hemostatic material in medical use technical fields, treat more specifically, it is related to a kind of be closed for vein
Eccentric sexual oppression dressing and its production method afterwards.
Background technique
It needs to prick out blood outlet on the blood vessel of Venous leg varicose when treating varication, then covers hemostatic gauze
On blood outlet, then varication socks are put on, hemostatic gauze, which is fixed on blood outlet, makes blood outlet heal.
In the prior art, it can refer to the Chinese invention patent file that Authorization Notice No. is CN103800940B, it discloses
A kind of bleeding-stopping dressing and preparation method, include the following steps：Weigh mineral substance hemostasis granules, softening agent, adhesive, antibacterial material
Material promotees coagulant material and water；Mineral substance hemostasis granules, softening agent, adhesive are added to the water mixing, boiled, it is cooling, suppression is added
Bacterium material and rush coagulant material mix, and obtain hemostat suspension；By the hemostat suspension secure attachment in support matrix, do
It is dry to get arrive a kind of bleeding-stopping dressing.
Existing this bleeding-stopping dressing using using mineral substance hemostasis granules as a part of hemostatic material, mineral substance
Grain is bonded in support matrix under the action of adhesive, when mineral substance particle and wound contact, be easy to cause wound infection, because
This needs produce it is a kind of can quick-acting haemostatic powder and be capable of sterilizing for the eccentric sexual oppression dressing after vein closure treatment
And its production method.
Summary of the invention
In view of the deficiencies of the prior art, the present invention intends to provide it is a kind of for vein closure treatment after it is inclined
Disposition oppresses dressing, is impregnated by the way that fabric to be placed in hemostatic agent and sterilizing medicament, can prepare fast short stopping
Blood and the eccentric sexual oppression dressing being used for after vein closure treatment for capableing of sterilizing.
To achieve the above object, the present invention provides following technical solutions：A kind of bias being closed after treatment for vein
Sexual oppression dressing, including hemostatic gauze, hemostatic gauze include fabric, the hemostatic agent being immersed in fabric and sterilizing medicine
Agent；The mass ratio of the hemostatic agent and the sterilizing medicament is 1.3-1.5:0.6-0.9；The hemostatic agent be by with
Lower ingredient is prepared by weight：Tail 5-8 parts of Huanglong, 8-10 parts of iron amaranth grass, rich and honour 4-7 parts of dish, 5-9 parts of Seabuckthorn Oil, according to ground
Sour sodium 3-6 parts, 2-4 parts of Radix Notoginseng, 1-3 parts of aizoon stonecrop, 2.5-3.5 parts of saltcake, 1.5-2.5 parts of rheum officinale, 1-3 parts of sophora flower, red crowned crane
3-4 parts careless, 3-4 parts of folium artemisiae argyi, 1-3 parts of cattail pollen；The sterilizing medicament is prepared by weight by following component：Cassia bark
9-11 parts, 5-9 parts of Swertia vacillana (Hance) Maxim., 3-8 parts, 2-5 parts of the root of Dahurain angelica of tail ginseng.
By using above-mentioned technical proposal, contains agrimonine, agrimonolide, catechol etc. in Huanglong's tail, can contract
Short blood clotting time increases blood platelet, promotes the generation of blood platelet and can increase blood calcium, has preferable quick-acting haemostatic powder to act on；Iron
Amaranth grass can be clearing heat and detoxicating, cooling blood and hemostasis；Contain a large amount of phycocolloid element, mannitol, vitamin B, sulphur, potassium in the cauline leaf of rich and honour dish
And the nutrients such as a variety of amino acid, have the function of preferably stopping blooding；Total seabuckthorn flavone in Seabuckthorn Oil can reduce high blood
Rouge softens blood vessel, and can understand blood vessel deposit, removes the deposit of blood outlet clean；Radix Notoginseng, aizoon stonecrop
It can make local vasoconstriction, have the effect of good hemostatic analgesia；Saltcake is used together with rheum officinale, can be clearing heat and detoxicating,
Hemostasis convergence, swelling and pain relieving make wound fast convergence heal；Sophora flower chemical component containing there are many, wherein rutin and its glucoside are first
Quercetin is able to maintain the normal resistance of capillary, reduces vasopermeability, can increase the elasticity of capillary, reach fast
The blood vessel of short stopping blood；Hairyvein agrimony, folium artemisiae argyi and cattail pollen all have fast convergence hemostasis, shorten blood coagulation time, increase blood platelet
Quantity, inhibits the activity of fibrinolysin, and anastalsis is preferable；Cassia bark is able to suppress growing for a variety of pathomycetes, can
Sterilizing；Swertia vacillana (Hance) Maxim. has clearing heat and detoxicating, anti-inflammation and sterilization and other effects, can prevent blood outlet inflammation, inhibits bacterial growth；Tail
Ginseng and the root of Dahurain angelica can antipyretic-antalgic, inhibit fungi to grow；There is the Huanglong's bone for shortening blood clotting time, iron amaranth grass, richness using a variety of
Your dish etc., increases blood platelet, and the raw material of quick-acting haemostatic powder can make the outspoken short stopping blood of bleeding, and can restrain blood outlet, prevent again
Secondary bleeding；Using cassia bark, Swertia vacillana (Hance) Maxim., tail ginseng and the root of Dahurain angelica, it is able to suppress bacterial growth, prevents blood outlet from infecting, promotes blood outlet
Quickly healing.
The present invention is further arranged to：It further include scar agent of dispelling in the hemostatic gauze, scar agent and the hemostatic of dispelling
The mass ratio of agent is 0.2-0.4:1.3-1.5, the scar agent of dispelling is prepared by weight by following component：Asparagus juice 4-9
Part, it is cactus juice 2-6 parts fresh, 1-4 parts of honey.
By using above-mentioned technical proposal, asparagus juice is rich in aloe-emodin and Anthraquinone Complex, applies in bleeding
Blood outlet can be promoted to heal on mouthful, and make not stay scar at blood outlet；Cactus juice and honey being capable of sterilizations, reduction pain
Bitterly, promote wound healing, prevent from infecting, prevent blood outlet from staying scar；Scar agent of dispelling is added in hemostatic gauze, wound can be promoted to be cured
It closes, promotes myogenic growth, prevent blood outlet from staying scar.
The present invention is further arranged to：It further include analgestic in the hemostatic gauze, the analgestic and the hemostatic
The mass ratio of agent is 0.1-0.2:1.3-1.5, the analgestic include 6-10 parts of vitamin B12,3-6 parts of borneol, olibanum 4-7
Part, 1-4 parts of bush.
By using above-mentioned technical proposal, borneol can clearing away heat to and alleviating pain, detumescence, erosion prevention and muscle growing, promote blood outlet convergence be cured
It closes；Olibanum being capable of detumescence and promoting granulation, analgesic, convergence wound；Bush can reduce swelling, relieve pain；Analgestic, energy are added in hemostatic gauze
The pain for enough mitigating patient, promotes the healing of wound.
The present invention is further arranged to：It further include consolidant in the hemostatic gauze, the consolidant and the hemostatic
The mass ratio of agent is 0.3-0.5:1.3-1.5, the consolidant are prepared by weight by following component：Vitamin B2
4-8 parts, 5-10 parts of vitamin B6,4-9 parts of vitamin C.
By using above-mentioned technical proposal, cytothesis can be reduced swelling and be promoted to vitamin B2, promote the growth of skin, and
Vitamin B6 is public, and effect is more preferable, and vitamin B6 can protect vascular endothelial cell, and vitamin C can maintain immune function, keeps
Blood vessel is complete, blood outlet can be promoted to heal.
The present invention is further arranged to：It further include being wrapped in the mesh enclosure outside hemostatic gauze being used to prevent hemostatic gauze from scattering.
By using above-mentioned technical proposal, hemostatic gauze is wrapped in mesh enclosure, hemostatic gauze can be made more to concentrate deposited
It at blood outlet, and will not scatter, quick-acting haemostatic powder is carried out to blood outlet convenient for hemostatic gauze.
The present invention is further arranged to：It is provided on the side that the mesh enclosure is contacted with the hemostatic gauze for by mesh enclosure
The adhesive-layer being adhered on hemostatic gauze.
By using above-mentioned technical proposal, adhesive-layer of the mesh enclosure on hemostatic gauze side is set, net can be convenient for
Hemostatic gauze is closely wrapped in mesh enclosure by cover, prevents from scattering in the use process of hemostatic gauze.
The present invention is further arranged to：The adhesive-layer is to be prepared by following component by mass parts：Hempleaf nettle root 4-6
Part, 5-8 parts of the bletilla striata, 2-3 parts of dandelion, 3-4 parts of Fructus Forsythiae, 1-3 parts of Lasiosphaera fenzlii.
By using above-mentioned technical proposal, dandelion, Fructus Forsythiae being capable of clearing heat and detoxicating, anti-inflammatory analgetics；Lasiosphaera fenzlii has apparent
Haemostatic effect, and it is inhibited to pathomycete；The bletilla striata has effects that preferable astringing to arrest bleeding, detumescence and promoting granulation, may be used also
To inhibit fungi to grow；Hempleaf nettle root has the function of analgesic, and hempleaf nettle root and the bletilla striata all have being a bit sticky, can be by mesh enclosure
It is adhered on hemostatic gauze, prevents mesh enclosure from separating with hemostatic gauze, influence the use of hemostatic gauze.
The present invention is further arranged to：The mesh enclosure is made of elastic material.
By using above-mentioned technical proposal, the mesh enclosure made of elastic material has certain elasticity, can be packed into difference
The hemostatic gauze of amount can be packed into hemostatic gauze according to the size of hemostatic port, avoid the waste of hemostatic gauze, can save hemostatic yarn
The dosage of cloth.
In view of the deficienciess of the prior art, it is another object of the present invention to provide one kind for vein closure treatment
The production method of eccentric sexual oppression dressing afterwards is closed the eccentricity after treatment for vein using what the production method processed
Oppressing dressing being capable of quick-acting haemostatic powder and sterilizing.
To achieve the above object, the present invention provides following technical solutions：Include the following steps：
(1) taking total weight is 5-8 parts of Huanglong's tails, 8-10 parts of iron amaranths grass, 4-7 portion wealth and rank dishes, 5-9 parts of Seabuckthorn Oils and 3-6 parts according to ground
Sour 3.5-4.7 times of sodium total weight of pure water simultaneously boils, and 5-8 parts of Huanglong's tails, 8-10 parts of iron amaranth grass, 4- are successively added into boiling water
7 portions of rich and honour dishes, 5-9 parts of Seabuckthorn Oils and 3-6 parts of edetate sodiums are decocted twice, are decocted 1-2 hours every time, merge decocting after decocting
Liquid, and use filtering with microporous membrane；
(2) 2-4 portions of Radix Notoginseng, 1-3 portions of aizoon stonecrops, 2.5-3.5 parts of saltcake, 1.5-2.5 are added in gained filtrate into step (1)
Part rheum officinale, 1-3 parts of sophoras flower, 3-4 portions of hairyvein agrimonies, 3-4 portions of folium artemisiae argyis, 1-3 parts of cattail pollens decoct once, and decocting time is 2-3 hours,
With filtering with microporous membrane, filtrate is condensed into the medical fluid that relative density is 0.46, it is spare；
(3) taking gross mass is the pure water that 9-11 parts of cassia barks, the 2-5 parts of roots of Dahurain angelica, 3-8 parts of tails join 4.6-5.8 times of gross mass, to boiling
Water in 9-11 part cassia barks, the 2-5 part roots of Dahurain angelica, 3-8 parts of tails are added join, and boil, add 5-9 parts of Swertia vacillana (Hance) Maxim., decoction three times, often
Secondary decoction 2.5-3 hours, merge decoct after decocting liquid, and use filtering with microporous membrane, by filtrate be condensed into relative density be 0.43
Medical fluid, it is spare；
(4) 4-9 portions of asparagus juices are taken, are heated to 80-110 DEG C, under the revolving speed of 300-500 turns/min, are slowly added into asparagus juice
Enter 2-6 parts of cactus juices, be warming up to 120-130 DEG C after mixing evenly, revolving speed is improved to 600-800 and turns/min, to mixed liquor
1-4 parts of honey of middle addition stir evenly, spare；
(5) 3-6 parts of borneols, 4-7 parts of olibanums, 1-4 portions of bushes and 6-10 parts of vitamin B12s are taken to carry out ball mill grinding, ratio of grinding media to material is
1.8:1, Ball-milling Time 20-60min, it is spare
(6) 4-8 parts of vitamin B2s, 5-10 parts of vitamin B6s and 4-9 parts of vitamin Cs is taken to carry out ball mill grinding, ratio of grinding media to material 1.6:
1, Ball-milling Time 30-50min, it is spare；
(7) step (2) resulting liquid is heated to 100-120 DEG C, revolving speed be 200-300 turn/min under, by step (3) and
Mixed powder obtained in the resulting liquid of step (4) and step (5) and step (6) sequentially adds step (2) resulting liquid
In, room temperature is down to after keeping the temperature 20-30min；
It (8) is 1 by bath raio by fabric:30-50, which is placed in step (7) resulting mixed liquor, impregnates 40-60min, after dipping
Fabric take out, be dehydrated 5-8min；
(9) fabric dewatered in step (8) placement is carried out disinfection under ultraviolet light, disinfecting time 20-30min；
(10) adhesive-layer will be smeared on fabric, mesh enclosure set is obtained to the eccentricity pressure after being used for vein closure treatment on the fabric
Compel dressing.
By using above-mentioned technical proposal, Huanglong's tail, iron amaranth grass, rich and honour dish, Seabuckthorn Oil and edetate sodium are first carried out pan-fried
It boils, and decocts twice, the extract in each raw material can be extracted completely；It is added in the mixture in step (1)
Radix Notoginseng etc., decocts again, and the extract of Huanglong's tail and Radix Notoginseng etc. can be made to be sufficiently mixed and be, and extracts complete；Because cassia bark, white
It is withered that the root of Dahurian angelica and tail, which are proofread, it is difficult to it extracts, first boils cassia bark, the root of Dahurain angelica and tail ginseng in water, it can be convenient for extraction cassia bark, the root of Dahurain angelica
With the extract in tail ginseng；Asparagus juice heating can be played the role of into sterilizing, cactus juice is added under stiring, it can
It is uniformly mixed convenient for asparagus juice and cactus juice, because honey is more sticky, temperature is increased, can soften convenient for honey, mention
High revolving speed can be convenient for for honey being uniformly mixed with the mixture of asparagus juice and cactus juice；Because borneol has volatility, easily
Distillation；Olibanum preheating is easy softening；Vitamin B12 preheating has certain extent of the destruction, so can be incited somebody to action using ball mill grinding
The grindings such as borneol, olibanum are thinner；Vitamin B2 is stable when heating and vitamin B6 is non-refractory, so using ball milling
Pulverised form is ground；Finally resulting standby raw material is uniformly mixed, by the completely rear dehydration of fabric dipping, then ultraviolet light is carried out and kills
Bacterium disinfection produces quick-acting haemostatic powder and is capable of controlling for vein closure for sterilizing finally by hemostatic gauze upper cover upper guard
Eccentric sexual oppression dressing after treatment.
The present invention is further arranged to：Step (9) middle-ultraviolet lamp refers to C wave ultraviolet light, illumination wavelength 250-
270nm。
By using above-mentioned technical proposal, C wave ultraviolet light can result in that growth cell is extremely busy or regenerative cell is dead,
Have the function that sterilizing, fabric is sterilized under the wavelength of 250-270nm, can sterilize more thoroughly.
In conclusion the present invention has the advantages that compared with the prior art：
(1) present invention is impregnated by the way that fabric to be placed in hemostatic agent and sterilizing medicament, can prepare quick-acting haemostatic powder
And the eccentric sexual oppression dressing of sterilizing being used for after vein closure treatment；
(2) present invention can make bleeding by adding scar agent of dispelling in for the eccentric sexual oppression dressing after vein closure treatment
Mouth preventing from scar；
(3) present invention can reduce trouble by adding analgestic in for the eccentric sexual oppression dressing after vein closure treatment
The pain of person；
(4) present invention can promote by adding consolidant in for the eccentric sexual oppression dressing after vein closure treatment
The healing of blood mouth, shortens healing time；
(5) hemostatic gauze is wrapped with mesh enclosure by preparation in hemostatic gauze upper cover upper guard, prevents hemostatic gauze by the present invention
It scatters, the pressing for concentrating hemostatic gauze more is at blood outlet.
Specific embodiment
Embodiment 1：A kind of eccentric sexual oppression dressing after the closure treatment for vein, including hemostatic gauze and be wrapped in only
The mesh enclosure for being used to prevent hemostatic gauze from scattering outside blood gauze；Mesh enclosure is made of elastic material；Mesh enclosure contacted with hemostatic gauze one
The adhesive-layer for being adhered to hemostatic gauze on hemostatic gauze is provided on side；Adhesive-layer be by following component by mass parts and
At：4 parts of hempleaf nettle roots, 5 portions of bletilla striatas, 2 portions of dandelions, 3 parts of Fructus Forsythiaes and 1 part of Lasiosphaera fenzlii.
Wherein hemostatic gauze includes hemostatic agent, the sterilizing medicament, scar of dispelling agent, analgesia of fabric, dipping on the fabric
Agent and consolidant；Wherein the mass ratio of hemostatic agent, sterilizing medicament, scar of dispelling agent, analgestic and consolidant is 1.3:0.6:
0.2:0.1:0.3；
Hemostatic agent is to be prepared by following component by mass parts：5 parts of Huanglong's tails, 8 parts of iron amaranth grass, 4 portions of rich and honour dishes, 5 parts of sand
Spine oil, 3 parts of edetate sodiums, 2 portions of Radix Notoginseng；1 portion of aizoon stonecrop；2.5 parts of saltcake；1.5 parts of rheum officinales, 1 part of sophora flower, 3 parts of hairyvein agrimonies, 3
Part folium artemisiae argyi and 1 part of cattail pollen；Sterilizing medicament is to be prepared by following component by mass parts：9 parts of cassia barks, 5 parts of Swertia vacillana (Hance) Maxim., 3
Part tail ginseng and 2 parts of roots of Dahurain angelica；Scar of dispelling agent is to be prepared by following component by mass parts：4 portions of asparagus juices, 2 parts of fresh cactus juices
With 1 part of honey；Analgestic is to be prepared by following component by mass parts：6 parts of vitamin B12s, 3 parts of borneols, 4 parts of olibanums and 1
Part bush；Consolidant is to be prepared by following component by mass parts：4 parts of vitamin B2s, 5 parts of vitamin B6s and 4 parts of vitamins
C。
The production method of the eccentric sexual oppression dressing being used for after vein closure treatment includes the following steps：
(1) taking total weight is 5 parts of Huanglong's tails, 8 parts of iron amaranth grass, 4 portions of rich and honour dishes, 5 parts of Seabuckthorn Oils and 3 parts of edetate sodium total weights
3.5 times of pure water simultaneously boils, be successively added into boiling water 5 parts of Huanglong's tails, 8 parts of iron amaranth grass, 4 portions of rich and honour dishes, 5 parts of Seabuckthorn Oils and
3 parts of edetate sodiums decoct twice, decoct 1 hour every time, merge the decocting liquid after decocting, and use filtering with microporous membrane；
(2) 2 portions of Radix Notoginseng, 1 portion of aizoon stonecrop, 2.5 parts of saltcake, 1.5 parts of rheum officinales, 1 portion of Chinese scholartree are added in gained filtrate into step (1)
Flower, 3 portions of hairyvein agrimonies, 3 portions of folium artemisiae argyis, 1 part of cattail pollen decoct once, and decocting time is 2 hours, with filtering with microporous membrane, filtrate is dense
Shorten the medical fluid that relative density is 0.46 into, it is spare；
(3) taking gross mass is the pure water that 9 parts of cassia barks, 2 parts of roots of Dahurain angelica, 3 parts of tails join 4.6 times of gross mass, is added 9 into the water boiled
Part cassia bark, 2 parts of roots of Dahurain angelica, 3 parts of tails ginsengs, and boil, 5 parts of Swertia vacillana (Hance) Maxim. are added, decocts three times, decocts 2.5 hours every time, merging is decocted
Decocting liquid after boiling, and with filtering with microporous membrane, filtrate is condensed into the medical fluid that relative density is 0.43, it is spare；
(4) 4 portions of asparagus juices are taken, are heated to 80 DEG C, under the revolving speed of 300 turns/min, 2 portions of cactuses are slowly added into asparagus juice
Juice is warming up to 120 DEG C after mixing evenly, and revolving speed is improved to 600 turns/min, 1 part of honey is added into mixed liquor and stirs evenly,
It is spare；
(5) 3 parts of borneols, 4 parts of olibanums, 1 portion of bush and 6 parts of vitamin B12s is taken to carry out ball mill grinding, ratio of grinding media to material 1.8:1, ball milling
Time is 20min, spare；
(6) 4 parts of vitamin B2s, 5 parts of vitamin B6s and 4 parts of vitamin Cs is taken to carry out ball mill grinding, ratio of grinding media to material 1.6:1, when ball milling
Between be 30min, it is spare；
(7) step (2) resulting liquid is heated to 100 DEG C, in the case where revolving speed is 200 turns/min, by step (3) and step (4)
Mixed powder obtained in resulting liquid and step (5) and step (6) sequentially adds in step (2) resulting liquid, heat preservation
Room temperature is down to after 20min；
It (8) is 1 by bath raio by fabric:30 are placed in step (7) resulting mixed liquor and impregnate 40min, by the fabric after dipping
It takes out, is dehydrated 5min；
(9) dewatered fabric in step (8) is placed under C wave ultraviolet light and is carried out disinfection, illumination wavelength 250nm, disinfection
Time 20min；
(10) adhesive-layer will be smeared on fabric, mesh enclosure set is obtained to the eccentricity pressure after being used for vein closure treatment on the fabric
Compel dressing.
Embodiment 2：A kind of eccentric sexual oppression dressing after the closure treatment for vein, including hemostatic gauze and be wrapped in
The mesh enclosure for being used to prevent hemostatic gauze from scattering outside hemostatic gauze；Mesh enclosure is made of elastic material；Mesh enclosure is contacted with hemostatic gauze
The adhesive-layer for being adhered to hemostatic gauze on hemostatic gauze is provided on side；Adhesive-layer is by following component by mass parts
It forms：5 parts of hempleaf nettle roots, 6.5 portions of bletilla striatas, 2.5 portions of dandelions, 3.5 parts of Fructus Forsythiaes and 2 parts of Lasiosphaera fenzliis.
Wherein hemostatic gauze includes hemostatic agent, the sterilizing medicament, scar of dispelling agent, analgesia of fabric, dipping on the fabric
Agent and consolidant；Wherein the mass ratio of hemostatic agent, sterilizing medicament, scar of dispelling agent, analgestic and consolidant is 1.4:0.75:
0.3:0.15:0.4；
Hemostatic agent is to be prepared by following component by mass parts：6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7
Part Seabuckthorn Oil, 4.5 parts of edetate sodiums, 3 portions of Radix Notoginseng, 2 portions of aizoon stonecrops, 3 parts of saltcake, 2 parts of rheum officinales, 2 parts of sophoras flower, 3.5 portions of red crowned cranes
Grass, 3.5 portions of folium artemisiae argyis and 2 parts of cattail pollens；Sterilizing medicament is to be prepared by following component by mass parts：10 parts of cassia barks, 7 portions of blueness
Ye Dan, 5.5 parts of tail ginsengs and 3.5 parts of roots of Dahurain angelica；Scar of dispelling agent is to be prepared by following component by mass parts：6.5 portions of asparagus juices, 4 parts
Fresh cactus juice and 2.5 parts of honey；Analgestic is to be prepared by following component by mass parts：8 parts of vitamin B12s, 4.5 parts
Borneol, 5.5 parts of olibanums and 2.5 portions of bushes；Consolidant is to be prepared by following component by mass parts：6 parts of vitamin B2s, 7.5
Part vitamin B6 and 6.5 parts of vitamin Cs.
The production method of the eccentric sexual oppression dressing being used for after vein closure treatment includes the following steps：
(1) taking total weight is that 6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7 parts of Seabuckthorn Oils and 4.5 parts of edetate sodiums are total
The pure water that 4.1 times of weight simultaneously boils, and 6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7 parts are successively added into boiling water
Seabuckthorn Oil and 4.5 parts of edetate sodiums decoct twice, decoct 1 every time.5 hours, merge the decocting liquid after decocting, and use miillpore filter
Filtering；
(2) to be added in gained filtrate in step (1) 3 portions of Radix Notoginseng, 2 portions of aizoon stonecrops, 3 parts of saltcake, 2 parts of rheum officinales, 2 parts of sophoras flower,
3.5 portions of hairyvein agrimonies, 3.5 portions of folium artemisiae argyis and 2 parts of cattail pollens decoct once, and decocting time is 2.5 hours, with filtering with microporous membrane, will filter
Liquid is condensed into the medical fluid that relative density is 0.46, spare；
(3) taking gross mass is the pure water that 10 parts of cassia barks, 3.5 parts of roots of Dahurain angelica and 5.5 parts of tails join 5.2 times of gross mass, to the water boiled
10 parts of cassia barks of middle addition, 3.5 parts of roots of Dahurain angelica and 5.5 parts of tail ginsengs, and boil, 7 parts of Swertia vacillana (Hance) Maxim. are added, decocts three times, decocts every time
2.7 hours, merge decoct after decocting liquid, and use filtering with microporous membrane, by filtrate be condensed into relative density for 0.43 medical fluid, it is standby
With；
(4) 6.5 portions of asparagus juices are taken, are heated to 95 DEG C, under the revolving speed of 400 turns/min, 4 parts of celestial beings are slowly added into asparagus juice
Juice is slapped, is warming up to 125 DEG C after mixing evenly, revolving speed is improved to 700 turns/min, 2.5 parts of honey stirrings are added into mixed liquor
Uniformly, spare；
(5) 4.5 parts of borneols, 5.5 parts of olibanums, 2.5 portions of bushes and 8 parts of vitamin B12s is taken to carry out ball mill grinding, ratio of grinding media to material 1.8:
1, Ball-milling Time 40min, it is spare；
(6) 6 parts of vitamin B2s, 7.5 parts of vitamin B6s and 6.5 parts of vitamin Cs is taken to carry out ball mill grinding, ratio of grinding media to material 1.6:1, ball
Time consuming is 40min, spare；
(7) step (2) resulting liquid is heated to 110 DEG C, in the case where revolving speed is 250 turns/min, by step (3) and step (4)
Mixed powder obtained in resulting liquid and step (5) and step (6) sequentially adds in step (2) resulting liquid, heat preservation
Room temperature is down to after 25min；
It (8) is 1 by bath raio by fabric:40 are placed in step (7) resulting mixed liquor and impregnate 50min, by the fabric after dipping
It takes out, is dehydrated 6.5min；
(9) dewatered fabric in step (8) is placed under C wave ultraviolet light and is carried out disinfection, illumination wavelength 260nm, disinfection
Time 25min；
(10) adhesive-layer will be smeared on fabric, mesh enclosure set is obtained to the eccentricity pressure after being used for vein closure treatment on the fabric
Compel dressing.
Embodiment 3：A kind of eccentric sexual oppression dressing after the closure treatment for vein, including hemostatic gauze and be wrapped in only
The mesh enclosure for being used to prevent hemostatic gauze from scattering outside blood gauze；Mesh enclosure is made of elastic material；Mesh enclosure contacted with hemostatic gauze one
The adhesive-layer for being adhered to hemostatic gauze on hemostatic gauze is provided on side；Adhesive-layer be by following component by mass parts and
At：6 parts of hempleaf nettle roots, 8 portions of bletilla striatas, 3 portions of dandelions, 4 parts of Fructus Forsythiaes and 3 parts of Lasiosphaera fenzliis.
Wherein hemostatic gauze includes hemostatic agent, the sterilizing medicament, scar of dispelling agent, analgesia of fabric, dipping on the fabric
Agent and consolidant；Wherein the mass ratio of hemostatic agent, sterilizing medicament, scar of dispelling agent, analgestic and consolidant is 1.53:0.9:
0.4:0.2:0.5；
Hemostatic agent is to be prepared by following component by mass parts：8 parts of Huanglong's tails, 10 parts of iron amaranth grass, 7 portions of rich and honour dishes, 9 parts of sand
Spine oil, 6 parts of edetate sodiums, 4 portions of Radix Notoginseng, 3 portions of aizoon stonecrops, 3.5 parts of saltcake, 2.5 parts of rheum officinales, 3 parts of sophoras flower, 4 parts of hairyvein agrimonies, 4
Part folium artemisiae argyi, 3 parts of cattail pollens；Sterilizing medicament is to be prepared by following component by mass parts：11 parts of cassia barks, 9 parts of Swertia vacillana (Hance) Maxim., 8
Part tail ginseng and 5 parts of roots of Dahurain angelica；Scar of dispelling agent is to be prepared by following component by mass parts：9 portions of asparagus juices, 6 parts of fresh cactus juices
With 4 parts of honey；Analgestic is to be prepared by following component by mass parts：10 parts of vitamin B12s, 6 parts of borneols, 7 parts of olibanums and 4
Part bush；Consolidant is to be prepared by following component by mass parts：8 parts of vitamin B2s, 10 parts of vitamin B6s and 9 parts of vitamins
C。
The production method of the eccentric sexual oppression dressing being used for after vein closure treatment includes the following steps：
(1) taking total weight is 8 parts of Huanglong's tails, 10 parts of iron amaranth grass, 7 portions of rich and honour dishes, 9 parts of Seabuckthorn Oils and 6 parts of edetate sodium total weights
4.7 times of pure water simultaneously boils, and 8 parts of Huanglong's tails, 10 parts of iron amaranth grass, 7 portions of rich and honour dishes, 9 parts of Seabuckthorn Oils are successively added into boiling water
With 6 parts of edetate sodiums, decocts twice, decoct 2 hours every time, merge the decocting liquid after decocting, and use filtering with microporous membrane；
(2) 4 portions of Radix Notoginseng, 3 portions of aizoon stonecrops, 3.5 parts of saltcake, 2.5 parts of rheum officinales, 3 portions of Chinese scholartrees are added in gained filtrate into step (1)
Flower, 4 portions of hairyvein agrimonies, 4 portions of folium artemisiae argyis, 3 parts of cattail pollens decoct once, and decocting time is 3 hours, with filtering with microporous membrane, filtrate is dense
Shorten the medical fluid that relative density is 0.46 into, it is spare；
(3) taking gross mass is the pure water that 11 parts of cassia barks, 5 parts of roots of Dahurain angelica, 8 parts of tails join 5.8 times of gross mass, is added into the water boiled
11 parts of cassia barks, 5 parts of roots of Dahurain angelica, 8 parts of tail ginsengs, and boil, 9 parts of Swertia vacillana (Hance) Maxim. are added, decocts three times, decocts 3 hours every time, merge and decoct
Decocting liquid after boiling, and with filtering with microporous membrane, filtrate is condensed into the medical fluid that relative density is 0.43, it is spare；
(4) 9 portions of asparagus juices are taken, are heated to 110 DEG C, under the revolving speed of 500 turns/min, 6 parts of celestial beings are slowly added into asparagus juice
Juice is slapped, is warming up to 130 DEG C after mixing evenly, revolving speed is improved to 800 turns/min, it is equal that 4 parts of honey stirrings are added into mixed liquor
It is even, it is spare；
(5) 6 parts of borneols, 7 parts of olibanums, 4 portions of bushes and 10 parts of vitamin B12s is taken to carry out ball mill grinding, ratio of grinding media to material 1.8:1, ball
Time consuming is 60min, spare；
(6) 8 parts of vitamin B2s, 10 parts of vitamin B6s and 9 parts of vitamin Cs is taken to carry out ball mill grinding, ratio of grinding media to material 1.6:1, ball milling
Time is 50min, spare；
(7) step (2) resulting liquid is heated to 120 DEG C, in the case where revolving speed is 300 turns/min, by step (3) and step (4)
Mixed powder obtained in resulting liquid and step (5) and step (6) sequentially adds in step (2) resulting liquid, heat preservation
Room temperature is down to after 30min；
It (8) is 1 by bath raio by fabric:50 are placed in step (7) resulting mixed liquor and impregnate 60min, by the fabric after dipping
It takes out, is dehydrated 8min；
(9) dewatered fabric in step (8) is placed under C wave ultraviolet light and is carried out disinfection, illumination wavelength 270nm, disinfection
Time 30min；
(10) adhesive-layer will be smeared on fabric, mesh enclosure set is obtained to the eccentricity pressure after being used for vein closure treatment on the fabric
Compel dressing.
Comparative example 1：A kind of eccentric sexual oppression dressing after the closure treatment for vein, including hemostatic gauze and be wrapped in only
The mesh enclosure for being used to prevent hemostatic gauze from scattering outside blood gauze；Mesh enclosure is made of elastic material；Mesh enclosure contacted with hemostatic gauze one
The adhesive-layer for being adhered to hemostatic gauze on hemostatic gauze is provided on side；Adhesive-layer be by following component by mass parts and
At：5 parts of hempleaf nettle roots, 6.5 portions of bletilla striatas, 2.5 portions of dandelions, 3.5 parts of Fructus Forsythiaes and 2 parts of Lasiosphaera fenzliis.
Wherein hemostatic gauze includes fabric, sterilizing medicament, scar of dispelling agent, analgestic and the healing of dipping on the fabric
Agent；Wherein the mass ratio of sterilizing medicament, scar of dispelling agent, analgestic and consolidant is 0.75:0.3:0.15:0.4；
Sterilizing medicament is to be prepared by following component by mass parts：10 parts of cassia barks, 7 parts of Swertia vacillana (Hance) Maxim., 5.5 parts of tails ginseng and
3.5 parts of roots of Dahurain angelica；Scar of dispelling agent is to be prepared by following component by mass parts：6.5 portions of asparagus juices, 4 parts of fresh cactus juices and 2.5
Part honey；Analgestic is to be prepared by following component by mass parts：8 parts of vitamin B12s, 4.5 parts of borneols, 5.5 parts of olibanums and
2.5 portions of bushes；Consolidant is to be prepared by following component by mass parts：6 parts of vitamin B2s, 7.5 parts of vitamin B6s and 6.5 parts
Vitamin C.
The production method of the eccentric sexual oppression dressing being used for after vein closure treatment includes the following steps：
(1) 3 portions of Radix Notoginseng, 2 portions of aizoon stonecrops, 3 parts of saltcake, 2 parts of rheum officinales, 2 parts of sophoras flower, 3.5 portions of hairyvein agrimonies, 3.5 portions of folium artemisiae argyis and 2 are taken
Part cattail pollen decocts once, and decocting time is 2.5 hours, and with filtering with microporous membrane, it is 0.46 that filtrate, which is condensed into relative density,
Medical fluid, it is spare；
(2) taking gross mass is the pure water that 10 parts of cassia barks, 3.5 parts of roots of Dahurain angelica and 5.5 parts of tails join 5.2 times of gross mass, to the water boiled
10 parts of cassia barks of middle addition, 3.5 parts of roots of Dahurain angelica and 5.5 parts of tail ginsengs, and boil, 7 parts of Swertia vacillana (Hance) Maxim. are added, decocts three times, decocts every time
2.7 hours, merge decoct after decocting liquid, and use filtering with microporous membrane, by filtrate be condensed into relative density for 0.43 medical fluid, it is standby
With；
(3) 6.5 portions of asparagus juices are taken, are heated to 95 DEG C, under the revolving speed of 400 turns/min, 4 parts of celestial beings are slowly added into asparagus juice
Juice is slapped, is warming up to 125 DEG C after mixing evenly, revolving speed is improved to 700 turns/min, 2.5 parts of honey stirrings are added into mixed liquor
Uniformly, spare；
(4) 4.5 parts of borneols, 5.5 parts of olibanums, 2.5 portions of bushes and 8 parts of vitamin B12s is taken to carry out ball mill grinding, ratio of grinding media to material 1.8:
1, Ball-milling Time 40min, it is spare；
(5) 6 parts of vitamin B2s, 7.5 parts of vitamin B6s and 6.5 parts of vitamin Cs is taken to carry out ball mill grinding, ratio of grinding media to material 1.6:1, ball
Time consuming is 40min, spare；
(6) step (1) resulting liquid is heated to 110 DEG C, in the case where revolving speed is 250 turns/min, by step (2) and step (3)
Mixed powder obtained in resulting liquid and step (4) and step (5) sequentially adds in step (1) resulting liquid, heat preservation
Room temperature is down to after 25min；
It (7) is 1 by bath raio by fabric:40 are placed in step (6) resulting mixed liquor and impregnate 50min, by the fabric after dipping
It takes out, is dehydrated 6.5min；
(8) dewatered fabric in step (7) is placed under C wave ultraviolet light and is carried out disinfection, illumination wavelength 260nm, disinfection
Time 25min；
(9) adhesive-layer will be smeared on fabric, mesh enclosure set is obtained to the eccentricity pressure after being used for vein closure treatment on the fabric
Compel dressing.
Comparative example 2：A kind of eccentric sexual oppression dressing after the closure treatment for vein, including hemostatic gauze and be wrapped in only
The mesh enclosure for being used to prevent hemostatic gauze from scattering outside blood gauze；Mesh enclosure is made of elastic material；Mesh enclosure contacted with hemostatic gauze one
The adhesive-layer for being adhered to hemostatic gauze on hemostatic gauze is provided on side；Adhesive-layer be by following component by mass parts and
At：5 parts of hempleaf nettle roots, 6.5 portions of bletilla striatas, 2.5 portions of dandelions, 3.5 parts of Fructus Forsythiaes and 2 parts of Lasiosphaera fenzliis.
Wherein hemostatic gauze includes fabric, hemostatic agent, scar of dispelling agent, analgestic and the consolidant of dipping on the fabric；Its
Middle hemostatic agent, scar of dispelling agent, analgestic and consolidant mass ratio be 1.4:0.3:0.15:0.4；
Hemostatic agent is to be prepared by following component by mass parts：6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7
Part Seabuckthorn Oil, 4.5 parts of edetate sodiums, 3 portions of Radix Notoginseng, 2 portions of aizoon stonecrops, 3 parts of saltcake, 2 parts of rheum officinales, 2 parts of sophoras flower, 3.5 portions of red crowned cranes
Grass, 3.5 portions of folium artemisiae argyis and 2 parts of cattail pollens；Scar of dispelling agent is to be prepared by following component by mass parts：6.5 portions of asparagus juices, 4 parts it is fresh
Cactus juice and 2.5 parts of honey；Analgestic is to be prepared by following component by mass parts：8 parts of vitamin B12s, 4.5 parts of ice
Piece, 5.5 parts of olibanums and 2.5 portions of bushes；Consolidant is to be prepared by following component by mass parts：6 parts of vitamin B2s, 7.5 parts
Vitamin B6 and 6.5 parts of vitamin Cs.
The production method of the eccentric sexual oppression dressing being used for after vein closure treatment includes the following steps：
(1) taking total weight is that 6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7 parts of Seabuckthorn Oils and 4.5 parts of edetate sodiums are total
The pure water that 4.1 times of weight simultaneously boils, and 6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7 parts are successively added into boiling water
Seabuckthorn Oil and 4.5 parts of edetate sodiums decoct twice, decoct 1 every time.5 hours, merge the decocting liquid after decocting, and use miillpore filter
Filtering；
(2) to be added in gained filtrate in step (1) 3 portions of Radix Notoginseng, 2 portions of aizoon stonecrops, 3 parts of saltcake, 2 parts of rheum officinales, 2 parts of sophoras flower,
3.5 portions of hairyvein agrimonies, 3.5 portions of folium artemisiae argyis and 2 parts of cattail pollens decoct once, and decocting time is 2.5 hours, with filtering with microporous membrane, will filter
Liquid is condensed into the medical fluid that relative density is 0.46, spare；
(3) 6.5 portions of asparagus juices are taken, are heated to 95 DEG C, under the revolving speed of 400 turns/min, 4 parts of celestial beings are slowly added into asparagus juice
Juice is slapped, is warming up to 125 DEG C after mixing evenly, revolving speed is improved to 700 turns/min, 2.5 parts of honey stirrings are added into mixed liquor
Uniformly, spare；
(4) 4.5 parts of borneols, 5.5 parts of olibanums, 2.5 portions of bushes and 8 parts of vitamin B12s is taken to carry out ball mill grinding, ratio of grinding media to material 1.8:
1, Ball-milling Time 40min, it is spare；
(5) 6 parts of vitamin B2s, 7.5 parts of vitamin B6s and 6.5 parts of vitamin Cs is taken to carry out ball mill grinding, ratio of grinding media to material 1.6:1, ball
Time consuming is 40min, spare；
(6) step (2) resulting liquid is heated to 110 DEG C, in the case where revolving speed is 250 turns/min, by step (3) resulting liquid
Mixed powder obtained in body and step (4) and step (5) sequentially adds in step (2) resulting liquid, after keeping the temperature 25min
It is down to room temperature；
It (7) is 1 by bath raio by fabric:40 are placed in step (6) resulting mixed liquor and impregnate 50min, by the fabric after dipping
It takes out, is dehydrated 6.5min；
(8) dewatered fabric in step (7) is placed under C wave ultraviolet light and is carried out disinfection, illumination wavelength 260nm, disinfection
Time 25min；
(9) adhesive-layer will be smeared on fabric, mesh enclosure set is obtained to the eccentricity pressure after being used for vein closure treatment on the fabric
Compel dressing.
Comparative example 3：A kind of eccentric sexual oppression dressing after the closure treatment for vein, including hemostatic gauze and be wrapped in only
The mesh enclosure for being used to prevent hemostatic gauze from scattering outside blood gauze；Mesh enclosure is made of elastic material；Mesh enclosure contacted with hemostatic gauze one
The adhesive-layer for being adhered to hemostatic gauze on hemostatic gauze is provided on side；Adhesive-layer be by following component by mass parts and
At：5 parts of hempleaf nettle roots, 6.5 portions of bletilla striatas, 2.5 portions of dandelions, 3.5 parts of Fructus Forsythiaes and 2 parts of Lasiosphaera fenzliis.
Wherein hemostatic gauze includes fabric, hemostatic agent, sterilizing medicament, analgestic and the healing of dipping on the fabric
Agent；Wherein the mass ratio of hemostatic agent, sterilizing medicament, analgestic and consolidant is 1.4:0.75:0.15:0.4；
Hemostatic agent is to be prepared by following component by mass parts：6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7
Part Seabuckthorn Oil, 4.5 parts of edetate sodiums, 3 portions of Radix Notoginseng, 2 portions of aizoon stonecrops, 3 parts of saltcake, 2 parts of rheum officinales, 2 parts of sophoras flower, 3.5 portions of red crowned cranes
Grass, 3.5 portions of folium artemisiae argyis and 2 parts of cattail pollens；Sterilizing medicament is to be prepared by following component by mass parts：10 parts of cassia barks, 7 portions of blueness
Ye Dan, 5.5 parts of tail ginsengs and 3.5 parts of roots of Dahurain angelica；Analgestic is to be prepared by following component by mass parts：8 parts of vitamin B12s, 4.5
Part borneol, 5.5 parts of olibanums and 2.5 portions of bushes；Consolidant is to be prepared by following component by mass parts：6 parts of vitamin B2s,
7.5 parts of vitamin B6s and 6.5 parts of vitamin Cs.
The production method of the eccentric sexual oppression dressing being used for after vein closure treatment includes the following steps：
(1) taking total weight is that 6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7 parts of Seabuckthorn Oils and 4.5 parts of edetate sodiums are total
The pure water that 4.1 times of weight simultaneously boils, and 6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7 parts are successively added into boiling water
Seabuckthorn Oil and 4.5 parts of edetate sodiums decoct twice, decoct 1 every time.5 hours, merge the decocting liquid after decocting, and use miillpore filter
Filtering；
(2) to be added in gained filtrate in step (1) 3 portions of Radix Notoginseng, 2 portions of aizoon stonecrops, 3 parts of saltcake, 2 parts of rheum officinales, 2 parts of sophoras flower,
3.5 portions of hairyvein agrimonies, 3.5 portions of folium artemisiae argyis and 2 parts of cattail pollens decoct once, and decocting time is 2.5 hours, with filtering with microporous membrane, will filter
Liquid is condensed into the medical fluid that relative density is 0.46, spare；
(3) taking gross mass is the pure water that 10 parts of cassia barks, 3.5 parts of roots of Dahurain angelica and 5.5 parts of tails join 5.2 times of gross mass, to the water boiled
10 parts of cassia barks of middle addition, 3.5 parts of roots of Dahurain angelica and 5.5 parts of tail ginsengs, and boil, 7 parts of Swertia vacillana (Hance) Maxim. are added, decocts three times, decocts every time
2.7 hours, merge decoct after decocting liquid, and use filtering with microporous membrane, by filtrate be condensed into relative density for 0.43 medical fluid, it is standby
With；
(4) 4.5 parts of borneols, 5.5 parts of olibanums, 2.5 portions of bushes and 8 parts of vitamin B12s is taken to carry out ball mill grinding, ratio of grinding media to material 1.8:
1, Ball-milling Time 40min, it is spare；
(5) 6 parts of vitamin B2s, 7.5 parts of vitamin B6s and 6.5 parts of vitamin Cs is taken to carry out ball mill grinding, ratio of grinding media to material 1.6:1, ball
Time consuming is 40min, spare；
(6) step (2) resulting liquid is heated to 110 DEG C, in the case where revolving speed is 250 turns/min, by step (3) resulting liquid
Mixed powder obtained in body and step (4) and step (5) sequentially adds in step (2) resulting liquid, after keeping the temperature 25min
It is down to room temperature；
It (7) is 1 by bath raio by fabric:40 are placed in step (6) resulting mixed liquor and impregnate 50min, by the fabric after dipping
It takes out, is dehydrated 6.5min；
(8) dewatered fabric in step (7) is placed under C wave ultraviolet light and is carried out disinfection, illumination wavelength 260nm, disinfection
Time 25min；
(9) adhesive-layer will be smeared on fabric, mesh enclosure set is obtained to the eccentricity pressure after being used for vein closure treatment on the fabric
Compel dressing.
Comparative example 4：A kind of eccentric sexual oppression dressing after the closure treatment for vein, including hemostatic gauze and be wrapped in only
The mesh enclosure for being used to prevent hemostatic gauze from scattering outside blood gauze；Mesh enclosure is made of elastic material；Mesh enclosure contacted with hemostatic gauze one
The adhesive-layer for being adhered to hemostatic gauze on hemostatic gauze is provided on side；Adhesive-layer be by following component by mass parts and
At：5 parts of hempleaf nettle roots, 6.5 portions of bletilla striatas, 2.5 portions of dandelions, 3.5 parts of Fructus Forsythiaes and 2 parts of Lasiosphaera fenzliis.
Wherein hemostatic gauze includes hemostatic agent, the sterilizing medicament, scar of dispelling agent, analgesia of fabric, dipping on the fabric
Agent and consolidant；Wherein hemostatic agent, sterilizing medicament, scar of dispelling agent, consolidant mass ratio be 1.4:0.75:0.3:0.4；
Hemostatic agent is to be prepared by following component by mass parts：6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7
Part Seabuckthorn Oil, 4.5 parts of edetate sodiums, 3 portions of Radix Notoginseng, 2 portions of aizoon stonecrops, 3 parts of saltcake, 2 parts of rheum officinales, 2 parts of sophoras flower, 3.5 portions of red crowned cranes
Grass, 3.5 portions of folium artemisiae argyis and 2 parts of cattail pollens；Sterilizing medicament is to be prepared by following component by mass parts：10 parts of cassia barks, 7 portions of blueness
Ye Dan, 5.5 parts of tail ginsengs and 3.5 parts of roots of Dahurain angelica；Scar of dispelling agent is to be prepared by following component by mass parts：6.5 portions of asparagus juices, 4 parts
Fresh cactus juice and 2.5 parts of honey；Consolidant is to be prepared by following component by mass parts：6 parts of vitamin B2s, 7.5 parts
Vitamin B6 and 6.5 parts of vitamin Cs.
The production method of the eccentric sexual oppression dressing being used for after vein closure treatment includes the following steps：
(1) taking total weight is that 6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7 parts of Seabuckthorn Oils and 4.5 parts of edetate sodiums are total
The pure water that 4.1 times of weight simultaneously boils, and 6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7 parts are successively added into boiling water
Seabuckthorn Oil and 4.5 parts of edetate sodiums decoct twice, decoct 1 every time.5 hours, merge the decocting liquid after decocting, and use miillpore filter
Filtering；
(2) to be added in gained filtrate in step (1) 3 portions of Radix Notoginseng, 2 portions of aizoon stonecrops, 3 parts of saltcake, 2 parts of rheum officinales, 2 parts of sophoras flower,
3.5 portions of hairyvein agrimonies, 3.5 portions of folium artemisiae argyis and 2 parts of cattail pollens decoct once, and decocting time is 2.5 hours, with filtering with microporous membrane, will filter
Liquid is condensed into the medical fluid that relative density is 0.46, spare；
(3) taking gross mass is the pure water that 10 parts of cassia barks, 3.5 parts of roots of Dahurain angelica and 5.5 parts of tails join 5.2 times of gross mass, to the water boiled
10 parts of cassia barks of middle addition, 3.5 parts of roots of Dahurain angelica and 5.5 parts of tail ginsengs, and boil, 7 parts of Swertia vacillana (Hance) Maxim. are added, decocts three times, decocts every time
2.7 hours, merge decoct after decocting liquid, and use filtering with microporous membrane, by filtrate be condensed into relative density for 0.43 medical fluid, it is standby
With；
(4) 6.5 portions of asparagus juices are taken, are heated to 95 DEG C, under the revolving speed of 400 turns/min, 4 parts of celestial beings are slowly added into asparagus juice
Juice is slapped, is warming up to 125 DEG C after mixing evenly, revolving speed is improved to 700 turns/min, 2.5 parts of honey stirrings are added into mixed liquor
Uniformly, spare；
(5) 6 parts of vitamin B2s, 7.5 parts of vitamin B6s and 6.5 parts of vitamin Cs is taken to carry out ball mill grinding, ratio of grinding media to material 1.6:1, ball
Time consuming is 40min, spare；
(6) step (2) resulting liquid is heated to 110 DEG C, in the case where revolving speed is 250 turns/min, by step (3) and step (4)
Mixed powder obtained in resulting liquid and step (5) sequentially adds in step (2) resulting liquid, drops after keeping the temperature 25min
To room temperature；
It (7) is 1 by bath raio by fabric:40 are placed in step (6) resulting mixed liquor and impregnate 50min, by the fabric after dipping
It takes out, is dehydrated 6.5min；
(8) dewatered fabric in step (7) is placed under C wave ultraviolet light and is carried out disinfection, illumination wavelength 260nm, disinfection
Time 25min；
(9) adhesive-layer will be smeared on fabric, mesh enclosure set is obtained to the eccentricity pressure after being used for vein closure treatment on the fabric
Compel dressing.
Comparative example 5：A kind of eccentric sexual oppression dressing after the closure treatment for vein, including hemostatic gauze and be wrapped in only
The mesh enclosure for being used to prevent hemostatic gauze from scattering outside blood gauze；Mesh enclosure is made of elastic material；Mesh enclosure contacted with hemostatic gauze one
The adhesive-layer for being adhered to hemostatic gauze on hemostatic gauze is provided on side；Adhesive-layer be by following component by mass parts and
At：5 parts of hempleaf nettle roots, 6.5 portions of bletilla striatas, 2.5 portions of dandelions, 3.5 parts of Fructus Forsythiaes and 2 parts of Lasiosphaera fenzliis.
Wherein hemostatic gauze includes hemostatic agent, the sterilizing medicament, scar of dispelling agent, analgesia of fabric, dipping on the fabric
Agent and consolidant；Wherein hemostatic agent, sterilizing medicament, scar of dispelling agent, analgestic mass ratio be 1.4:0.75:0.3:
0.15；
Hemostatic agent is to be prepared by following component by mass parts：6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7
Part Seabuckthorn Oil, 4.5 parts of edetate sodiums, 3 portions of Radix Notoginseng, 2 portions of aizoon stonecrops, 3 parts of saltcake, 2 parts of rheum officinales, 2 parts of sophoras flower, 3.5 portions of red crowned cranes
Grass, 3.5 portions of folium artemisiae argyis and 2 parts of cattail pollens；Sterilizing medicament is to be prepared by following component by mass parts：10 parts of cassia barks, 7 portions of blueness
Ye Dan, 5.5 parts of tail ginsengs and 3.5 parts of roots of Dahurain angelica；Scar of dispelling agent is to be prepared by following component by mass parts：6.5 portions of asparagus juices, 4 parts
Fresh cactus juice and 2.5 parts of honey；Analgestic is to be prepared by following component by mass parts：8 parts of vitamin B12s, 4.5 parts
Borneol, 5.5 parts of olibanums and 2.5 portions of bushes.
The production method of the eccentric sexual oppression dressing being used for after vein closure treatment includes the following steps：
(1) taking total weight is that 6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7 parts of Seabuckthorn Oils and 4.5 parts of edetate sodiums are total
The pure water that 4.1 times of weight simultaneously boils, and 6.5 parts of Huanglong's tails, 9 parts of iron amaranth grass, 5.5 portions of rich and honour dishes, 7 parts are successively added into boiling water
Seabuckthorn Oil and 4.5 parts of edetate sodiums decoct twice, decoct 1 every time.5 hours, merge the decocting liquid after decocting, and use miillpore filter
Filtering；
(2) to be added in gained filtrate in step (1) 3 portions of Radix Notoginseng, 2 portions of aizoon stonecrops, 3 parts of saltcake, 2 parts of rheum officinales, 2 parts of sophoras flower,
3.5 portions of hairyvein agrimonies, 3.5 portions of folium artemisiae argyis and 2 parts of cattail pollens decoct once, and decocting time is 2.5 hours, with filtering with microporous membrane, will filter
Liquid is condensed into the medical fluid that relative density is 0.46, spare；
(3) taking gross mass is the pure water that 10 parts of cassia barks, 3.5 parts of roots of Dahurain angelica and 5.5 parts of tails join 5.2 times of gross mass, to the water boiled
10 parts of cassia barks of middle addition, 3.5 parts of roots of Dahurain angelica and 5.5 parts of tail ginsengs, and boil, 7 parts of Swertia vacillana (Hance) Maxim. are added, decocts three times, decocts every time
2.7 hours, merge decoct after decocting liquid, and use filtering with microporous membrane, by filtrate be condensed into relative density for 0.43 medical fluid, it is standby
With；
(4) 6.5 portions of asparagus juices are taken, are heated to 95 DEG C, under the revolving speed of 400 turns/min, 4 parts of celestial beings are slowly added into asparagus juice
Juice is slapped, is warming up to 125 DEG C after mixing evenly, revolving speed is improved to 700 turns/min, 2.5 parts of honey stirrings are added into mixed liquor
Uniformly, spare；
(5) 4.5 parts of borneols, 5.5 parts of olibanums, 2.5 portions of bushes and 8 parts of vitamin B12s is taken to carry out ball mill grinding, ratio of grinding media to material 1.8:
1, Ball-milling Time 40min, it is spare；
(6) step (2) resulting liquid is heated to 110 DEG C, in the case where revolving speed is 250 turns/min, by step (3) and step (4)
Mixed powder obtained in resulting liquid and step (5) sequentially adds in step (2) resulting liquid, drops after keeping the temperature 25min
To room temperature；
It (7) is 1 by bath raio by fabric:40 are placed in step (6) resulting mixed liquor and impregnate 50min, by the fabric after dipping
It takes out, is dehydrated 6.5min；
(8) dewatered fabric in step (7) is placed under C wave ultraviolet light and is carried out disinfection, illumination wavelength 260nm, disinfection
Time 25min；
(9) adhesive-layer will be smeared on fabric, mesh enclosure set is obtained to the eccentricity pressure after being used for vein closure treatment on the fabric
Compel dressing.
The dosage of each ingredient is as shown in table 1 in each embodiment and each comparative example：
Each Ingredient Amount table in each embodiment of table 1 and each comparative example
Hemostasis experiment：Experimental rabbit is equally divided into 7 groups, including embodiment 1-2 and comparative example 1-5, experimental rabbit ear is lost hair or feathers,
It sterilizes, under aseptic condition at rabbit ear edge end 1/3, the blood outlet of 1cm long is cut with sterile surgical knife, including ear center
One aorta is cut open, but ear is not thorough, and anti-Hemostatic Oral Liquid is flowed out from inside, carries out subsequent blood coagulation after blood is full of the surface of a wound
Test weighs the quality (m for the eccentric sexual oppression dressing after vein closure treatment1), hemostasis is crushed, takes away and is used for after 10s
Eccentric sexual oppression dressing after vein closure treatment, observes haemostatic effect.When no more blood record when flowing out from blood outlet
Between T1, every 5s observation is primary later, until hemostasis completely, records time T2, bleeding stopping period T1And T2Average value.Stop blooding
Cheng Hou weighs the quality (m for the eccentric sexual oppression dressing after vein closure treatment of sucking blood2), calculate amount of bleeding m=
m2-m1。
Healing Experiments：Mouse is equally divided into 7 groups, including embodiment 1-2 and comparative example 1-5, with 3% yellow Jackets
30mg/kg intraperitoneal injection anesthesia, back of mice backbone two sides are lost hair or feathers, and lose hair or feathers area 4cm2, hair removal section is scalded with boiled water,
With for the eccentric sexual oppression dressing wound coverage face after vein closure treatment, daily dressing is primary.
Performance indexes of the table 1 for the eccentric sexual oppression dressing after vein closure treatment
By being used for the performance indexes of the eccentric sexual oppression dressing after vein closure is treated in table 1 it is found that adding in embodiment 1-3
Add hemostatic agent, sterilizing medicament, scar of dispelling agent, analgestic and consolidant, shortens the bleeding time, reduce amount of bleeding, is noninductive
Contaminate phenomenon, without scar, without lather phenomenon and healing time it is short；In comparative example 1 without Huanglong's tail, iron amaranth grass, rich and honour dish,
Seabuckthorn Oil, edetate sodium, bleeding stopping period is significantly longer, and amount of bleeding is larger；Sterilizing medicament in comparative example 2 goes out at blood outlet
Existing infection phenomenons；Without dispelling scar agent in comparative example 3, there are scars at blood outlet；Without analgestic in comparative example 4；Rabbit and mouse go out
Now serious lather phenomenon；Without consolidant in comparative example 5, the healing time of mouse wound face is longer；Therefore Huanglong's tail, iron amaranth
Grass, rich and honour dish, Seabuckthorn Oil, edetate sodium can shorten bleeding stopping period, reduce amount of bleeding；Sterilizing medicament is able to suppress bacterium
It grows, uses wound face without infection phenomenons；Scar of dispelling agent can erosion prevention and muscle growing, make wound face without scar；Analgestic can reduce swelling only
Bitterly；Consolidant can promote wound healing, shorten healing time.
The above is only a preferred embodiment of the present invention, protection scope of the present invention is not limited merely to above-mentioned implementation
Example, all technical solutions belonged under thinking of the present invention all belong to the scope of protection of the present invention.It should be pointed out that for the art
Those of ordinary skill for, several improvements and modifications without departing from the principles of the present invention, these improvements and modifications
It should be regarded as protection scope of the present invention.
Claims (10)
1. the eccentric sexual oppression dressing after a kind of closure treatment for vein, it is characterised in that：Including hemostatic gauze, hemostatic gauze
Including fabric, the hemostatic agent being immersed in fabric and sterilizing medicament；
The mass ratio of the hemostatic agent and the sterilizing medicament is 1.3-1.5:0.6-0.9；
The hemostatic agent is prepared by weight by following component：Tail 5-8 parts of Huanglong, 8-10 parts of iron amaranth grass, rich and honour dish
4-7 parts, 5-9 parts of Seabuckthorn Oil, 3-6 parts of edetate sodium, 2-4 parts of Radix Notoginseng, 1-3 parts of aizoon stonecrop, 2.5-3.5 parts of saltcake, rheum officinale
1.5-2.5 parts, 1-3 parts of sophora flower, 3-4 parts of hairyvein agrimony, 3-4 parts of folium artemisiae argyi, 1-3 parts of cattail pollen；
The sterilizing medicament is prepared by weight by following component：9-11 parts of cassia bark, 5-9 parts of Swertia vacillana (Hance) Maxim., tail ginseng
3-8 parts, 2-5 parts of the root of Dahurain angelica.
2. the eccentric sexual oppression dressing after the closure treatment according to claim 1 for vein, it is characterised in that：It is described to stop
It further include scar agent of dispelling in blood gauze, the mass ratio of dispel scar agent and the hemostatic agent is 0.2-0.4:1.3-1.5 described dispel
Scar agent is prepared by weight by following component：4-9 parts of asparagus juice, it is cactus juice 2-6 parts fresh, 1-4 parts of honey.
3. the eccentric sexual oppression dressing after the closure treatment according to claim 1 for vein, it is characterised in that：It is described to stop
It further include analgestic in blood gauze, the mass ratio of the analgestic and the hemostatic agent is 0.1-0.2:1.3-1.5 the town
Pain agent includes 6-10 parts of vitamin B12,3-6 parts of borneol, 4-7 parts of olibanum, 1-4 parts of bush.
4. the eccentric sexual oppression dressing after the closure treatment according to claim 1 for vein, it is characterised in that：It is described to stop
It further include consolidant in blood gauze, the mass ratio of the consolidant and the hemostatic agent is 0.3-0.5:1.3-1.5 described be cured
Mixture is prepared by weight by following component：4-8 parts of vitamin B2,5-10 parts of vitamin B6, vitamin C 4-9
Part.
5. the eccentric sexual oppression dressing after the closure treatment according to claim 1 for vein, it is characterised in that：Further include
It is wrapped in the mesh enclosure outside hemostatic gauze being used to prevent hemostatic gauze from scattering.
6. the eccentric sexual oppression dressing after the closure treatment according to claim 5 for vein, it is characterised in that：The net
Cover the adhesive-layer being provided on the side contacted with the hemostatic gauze for being adhered to mesh enclosure on hemostatic gauze.
7. the eccentric sexual oppression dressing after the closure treatment according to claim 6 for vein, it is characterised in that：It is described viscous
Glue-line is to be prepared by following component by mass parts：4-6 parts of hempleaf nettle root, 5-8 parts of the bletilla striata, 2-3 parts of dandelion, 3-4 parts of Fructus Forsythiae,
1-3 parts of Lasiosphaera fenzlii.
8. the eccentric sexual oppression dressing after the closure treatment according to claim 5 for vein, it is characterised in that：The net
Cover is made of elastic material.
9. a kind of production of the eccentric sexual oppression dressing after closure treatment according to claim 1-8 for vein
Method, it is characterised in that：Include the following steps：
(1) taking total weight is 5-8 parts of Huanglong's tails, 8-10 parts of iron amaranths grass, 4-7 portion wealth and rank dishes, 5-9 parts of Seabuckthorn Oils and 3-6 parts according to ground
Sour 3.5-4.7 times of sodium total weight of pure water simultaneously boils, and 5-8 parts of Huanglong's tails, 8-10 parts of iron amaranth grass, 4- are successively added into boiling water
7 portions of rich and honour dishes, 5-9 parts of Seabuckthorn Oils and 3-6 parts of edetate sodiums are decocted twice, are decocted 1-2 hours every time, merge decocting after decocting
Liquid, and use filtering with microporous membrane；
(2) 2-4 portions of Radix Notoginseng, 1-3 portions of aizoon stonecrops, 2.5-3.5 parts of saltcake, 1.5-2.5 are added in gained filtrate into step (1)
Part rheum officinale, 1-3 parts of sophoras flower, 3-4 portions of hairyvein agrimonies, 3-4 portions of folium artemisiae argyis, 1-3 parts of cattail pollens decoct once, and decocting time is 2-3 hours,
With filtering with microporous membrane, filtrate is condensed into the medical fluid that relative density is 0.46, it is spare；
(3) taking gross mass is the pure water that 9-11 parts of cassia barks, the 2-5 parts of roots of Dahurain angelica, 3-8 parts of tails join 4.6-5.8 times of gross mass, to boiling
Water in 9-11 part cassia barks, the 2-5 part roots of Dahurain angelica, 3-8 parts of tails are added join, and boil, add 5-9 parts of Swertia vacillana (Hance) Maxim., decoction three times, often
Secondary decoction 2.5-3 hours, merge decoct after decocting liquid, and use filtering with microporous membrane, by filtrate be condensed into relative density be 0.43
Medical fluid, it is spare；
(4) 4-9 portions of asparagus juices are taken, are heated to 80-110 DEG C, under the revolving speed of 300-500 turns/min, are slowly added into asparagus juice
Enter 2-6 parts of cactus juices, be warming up to 120-130 DEG C after mixing evenly, revolving speed is improved to 600-800 and turns/min, to mixed liquor
1-4 parts of honey of middle addition stir evenly, spare；
(5) 3-6 parts of borneols, 4-7 parts of olibanums, 1-4 portions of bushes and 6-10 parts of vitamin B12s are taken to carry out ball mill grinding, ratio of grinding media to material is
1.8:1, Ball-milling Time 20-60min, it is spare
(6) 4-8 parts of vitamin B2s, 5-10 parts of vitamin B6s and 4-9 parts of vitamin Cs is taken to carry out ball mill grinding, ratio of grinding media to material 1.6:
1, Ball-milling Time 30-50min, it is spare；
(7) step (2) resulting liquid is heated to 100-120 DEG C, revolving speed be 200-300 turn/min under, by step (3) and
Mixed powder obtained in the resulting liquid of step (4) and step (5) and step (6) sequentially adds step (2) resulting liquid
In, room temperature is down to after keeping the temperature 20-30min；
It (8) is 1 by bath raio by fabric:30-50, which is placed in step (7) resulting mixed liquor, impregnates 40-60min, after dipping
Fabric take out, be dehydrated 5-8min；
(9) fabric dewatered in step (8) placement is carried out disinfection under ultraviolet light, disinfecting time 20-30min；
(10) adhesive-layer will be smeared on fabric, mesh enclosure set is obtained to the eccentricity pressure after being used for vein closure treatment on the fabric
Compel dressing.
10. the production method of the eccentric sexual oppression dressing after the closure treatment according to claim 9 for vein, feature
It is：Step (9) middle-ultraviolet lamp refers to C wave ultraviolet light, illumination wavelength 250-270nm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810714443.5A CN108837173A (en) | 2018-06-29 | 2018-06-29 | A kind of eccentric sexual oppression dressing and its production method being closed after treatment for vein |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810714443.5A CN108837173A (en) | 2018-06-29 | 2018-06-29 | A kind of eccentric sexual oppression dressing and its production method being closed after treatment for vein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108837173A true CN108837173A (en) | 2018-11-20 |
Family
ID=64201120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810714443.5A Pending CN108837173A (en) | 2018-06-29 | 2018-06-29 | A kind of eccentric sexual oppression dressing and its production method being closed after treatment for vein |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108837173A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN202751503U (en) * | 2012-08-16 | 2013-02-27 | 浙江省肿瘤医院 | Medical gauze mesh enclosure |
| CN104161995A (en) * | 2014-08-25 | 2014-11-26 | 河南科技大学第一附属医院 | Bleeding stopping and blood coagulating powder used for traumatic hemorrhage and preparation method thereof |
| CN105194560A (en) * | 2015-10-23 | 2015-12-30 | 亓亮 | Traditional Chinese medicinal composition for treating general surgical wound |
| CN105311391A (en) * | 2015-01-26 | 2016-02-10 | 杨家驥 | Chinese herbal medicine for treating open wound and preparation method thereof |
| US9295700B1 (en) * | 2015-11-17 | 2016-03-29 | Abdulmohsen Ebrahim Al-Terki | Wound healing composition |
-
2018
- 2018-06-29 CN CN201810714443.5A patent/CN108837173A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN202751503U (en) * | 2012-08-16 | 2013-02-27 | 浙江省肿瘤医院 | Medical gauze mesh enclosure |
| CN104161995A (en) * | 2014-08-25 | 2014-11-26 | 河南科技大学第一附属医院 | Bleeding stopping and blood coagulating powder used for traumatic hemorrhage and preparation method thereof |
| CN105311391A (en) * | 2015-01-26 | 2016-02-10 | 杨家驥 | Chinese herbal medicine for treating open wound and preparation method thereof |
| CN105194560A (en) * | 2015-10-23 | 2015-12-30 | 亓亮 | Traditional Chinese medicinal composition for treating general surgical wound |
| US9295700B1 (en) * | 2015-11-17 | 2016-03-29 | Abdulmohsen Ebrahim Al-Terki | Wound healing composition |
Non-Patent Citations (5)
| Title |
|---|
| 张浩主编: "《心脏手术患者住院与康复指南》", 30 April 2016, 上海：上海科学技术出版社 * |
| 权正良编: "《高等院校急救手册》", 31 October 2012, 西安：陕西科学技术出版社 * |
| 李文汉等: "《儿科临床药理学》", 31 July 1998, 北京：人民卫生出版社 * |
| 邱方等: "《弥散性血管内凝血 诊治重点与典型病例》", 30 November 2017, 北京：科学技术文献出版社 * |
| 顾学裘编著: "《药物制剂注解》", 31 May 1965, 北京：人民卫生出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091203B (en) | External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof | |
| CN106620370A (en) | Traditional Chinese medicine for treating beriberi | |
| CN111467433B (en) | A topical Chinese medicinal composition and paste for promoting wound healing, and its preparation method | |
| CN102078373B (en) | Traditional Chinese medicinal composition for treating incised wounds, empyrosis and various wounds | |
| CN103948774A (en) | Traditional Chinese medicine solution for internal fistula care and preparation method thereof | |
| CN100393332C (en) | Tissue regenerating ointment with repercussive and toxin-draining functions | |
| CN103211894A (en) | Medicine for treating knife wound and preparation method thereof | |
| CN1443549A (en) | Medicine for preventing injury from producing scar | |
| CN102579915A (en) | Medicine for treating wound non-healing of diabetics and preparation method thereof | |
| CN108837173A (en) | A kind of eccentric sexual oppression dressing and its production method being closed after treatment for vein | |
| CN100502905C (en) | Chinese medicinal preparation for anti bacteria and promoting tissue regeneration | |
| CN102716402B (en) | External traditional Chinese medicine preparation for treating wound infection and preparation method thereof | |
| CN101732567B (en) | Medicament for treating burns and preparation method thereof | |
| CN101342287A (en) | Medical ointment for quickly knitting bone, relaxing tendons, and activating blood circulation, removing stasis, and preparation method thereof | |
| CN104721631A (en) | Traditional Chinese medicine composition for promoting wound healing and preparation method of traditional Chinese medicine composition | |
| CN108686092A (en) | Eliminate the Chinese medicinal aqua and preparation method thereof of scar | |
| CN109303821A (en) | It is a kind of to treat burn and scald, the external-applied ointment of bedsore and preparation application method | |
| CN109718333A (en) | A kind of Traditional Chinese medicine external preparation promoting wound healing | |
| CN1141105C (en) | Cancer curing medicine liquid | |
| CN105641150A (en) | Preparation method of liquid medicine for treating scalding | |
| CN106236900A (en) | A kind of for compound medicine treating burn and preparation method thereof | |
| CN1907443A (en) | Fuming-washing treating medicine for diolame-penis inflammation and its preparation | |
| CN105770199A (en) | Nursing traditional Chinese medicinal composition for treating burns and scalds | |
| CN105232650A (en) | Unguent for treating scalds and preparation and application methods thereof | |
| CN116036175A (en) | Cold compress composition for treating burns and scalds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181120 |
|
| RJ01 | Rejection of invention patent application after publication |